new IV immune globulin called RespiGam

You'll see a new IV immune globulin called RespiGam...formulated to prevent Respiratory Syncytial Virus (RSV) disease in children.

RSV is the leading cause of pneumonia in infants. Those at highest risk are premature infants...and children under age two with lung disease.

RespiGam is given to these high-risk children once a month during the RSV season...November to April.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote